NeuroOne Medical Technologies Corporation (NMTC) Operating cash flow 2016–2025
NeuroOne Medical Technologies Corporation (NMTC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$2.8MFY2025 · since FY2016: -$21,106 → -$2.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.8M | +74.2% |
| FY2024 | -$11.0M | +14.5% |
| FY2023 | -$12.9M | -71.4% |
| FY2022 | -$7.5M | +12.6% |
| FY2021 | -$8.6M | -151.2% |
| FY2020 | -$3.4M | +36.5% |
| FY2019 | -$5.4M | — |
| FY2017 | -$2.1M | -9888.0% |
| FY2016 | -$21,106 | — |
Source: SEC XBRL filings · For reference only · Not investment advice